Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Single-nucleotide polymorphisms in GALNT8 are associated with the response to interferon therapy for chronic hepatitis C.

Nakano R, Maekawa T, Abe H, Hayashida Y, Ochi H, Tsunoda T, Kumada H, Kamatani N, Nakamura Y, Chayama K.

J Gen Virol. 2013 Jan;94(Pt 1):81-9. doi: 10.1099/vir.0.044396-0. Epub 2012 Oct 3.

PMID:
23034592
2.

Host genetics.

Macías J, Vispo E, Pineda JA, Soriano V.

Curr Opin HIV AIDS. 2011 Nov;6(6):491-500. doi: 10.1097/COH.0b013e32834bca2d. Review.

PMID:
21918436
3.

Systematic review with meta-analysis: do interferon lambda 3 polymorphisms predict the outcome of interferon-therapy in hepatitis B infection?

Galmozzi E, Viganò M, Lampertico P.

Aliment Pharmacol Ther. 2014 Mar;39(6):569-78. doi: 10.1111/apt.12631. Epub 2014 Jan 26. Review.

4.

Activation of Type I and Type III Interferons in Chronic Hepatitis C.

Mihm S.

J Innate Immun. 2015;7(3):251-9. doi: 10.1159/000369973. Epub 2015 Jan 28. Review.

5.

Oral use of interferon.

Cummins JM, Beilharz MW, Krakowka S.

J Interferon Cytokine Res. 1999 Aug;19(8):853-7. Review.

PMID:
10476928

Supplemental Content

Support Center